No.

Publication Date

Citing Article

1

2021

Francesca Fenizia, Ilaria Alborelli, Jose Luis Costa, Claudia Vollbrecht, Beatriz Bellosillo, Winand Dinjens, Volker Endris, Carina Heydt, Katharina Leonards, Sabine Merkelback-Bruse, Nicole Pfarr, Ronald van Marion, Christopher Allen, Ruchi Chaudhary, Rajesh Gottimukkala, Fiona Hyland, Elaine Wong-Ho, Philip Jermann, Jose Carlos Machado, Michael Hummel, Albrecht Stenzinger, Nicola Normanno. Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis, The Journal of Molecular Diagnostics. 2021; 23: 882.  https://doi.org/10.1016/j.jmoldx.2021.04.008

2

2022

Anna Maria Rachiglio, Laura Forgione, Raffaella Pasquale, Carlo Antonio Barone, Evaristo Maiello, Lorenzo Antonuzzo, Antonino Cassata, Giuseppe Tonini, Roberto Bordonaro, Gerardo Rosati, Alberto Zaniboni, Sara Lonardi, Daris Ferrari, Giovanni Luca Frassineti, Stefano Tamberi, Salvatore Pisconti, Francesca Di Fabio, Cristin Roma, Armando Orlandi, Tiziana Latiano, Angela Damato, Giampaolo Tortora, Carmine Pinto, Nicola Normanno. Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies, Cancers. 2022; 14: 1052.  https://doi.org/10.3390/cancers14041052

3

2023

Anastasia A. Ponomaryova, Elena Yu. Rykova, Anastasia I. Solovyova, Anna S. Tarasova, Dmitry N. Kostromitsky, Alexey Yu. Dobrodeev, Sergey A. Afanasiev, Nadezhda V. Cherdyntseva. Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers, International Journal of Molecular Sciences. 2023; 24: 12407.  https://doi.org/10.3390/ijms241512407

4

2025

Anna Di Porzio, Annalisa Pecoraro, Camilla Danisi, Carolina Persico, Ludovica D’Auria, Marcello Germoglio, Nunzia Iaccarino, Isidoro Feliciello, Concetta Giancola, Antonio Randazzo, Giulia Russo, Annapina Russo. Reversing uL3-mediated chemoresistance through synergistic combination of 5-FU and G-quadruplex ligands, NAR Cancer. 2025; 7: zcaf046.  https://doi.org/10.1093/narcan/zcaf046

5

2025

Yudith Annisa Ayu Rezkitha, Isna Mahmudah, Supriyanto Supriyanto, Edwin Danardono, Langgeng Agung Waskito, Reny I'tishom, Yoshio Yamaoka, Muhammad Miftahussurur. The Suitable Biomarkers of Colorectal Cancer for Developing Countries, Research Journal of Pharmacy and Technology. 2025; 4527.  https://doi.org/10.52711/0974-360X.2025.00650

6

2026

Angela Damato, Riziero Esposito Abate, Simona Tessitore, Daniela Frezzetti, Monica Rosaria Maiello, Dario Righelli, Francesca Bergamo, Lorenzo Antonuzzo, Guglielmo Nasti, Filippo Pietrantonio, Giuseppe Tonini, Tiziana Latiano, Roberto Bordonaro, Gerardo Rosati, Elisa Giommoni, Francesco Iachetta, Mario Larocca, Evaristo Maiello, Sara Lonardi, Alessandra Romagnani, Giuseppe Maglietta, Antonella De Luca, Nicola Normanno, Carmine Pinto. First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial, Nature Communications. 2026;   https://doi.org/10.1038/s41467-026-70620-y

7

2022

Catuxa Celeiro Muñoz, María Sánchez Ares, José Ramón Antúnez López. 2022; 551.  https://doi.org/10.1016/B978-0-323-90055-3.00008-9

8

2024

Amandine Amalric, Aurore Attina, Amandine Bastide, Marion Buffard, Stéphanie Mateus, Chris Planque, Eric Rivals, Christophe Hirtz, Alexandre David. Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation, Analytical Chemistry. 2024; 96: 1825.  https://doi.org/10.1021/acs.analchem.3c02635